Puration Cannabis Infused Beverage Operation Prioritized In Canadian Deal
March 20 2018 - 9:15AM
InvestorsHub NewsWire
Dallas, TX -- March 20,
2018 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced its patented cannabis extraction capacity
and corresponding cannabis infused beverage business have been
pushed to the top priority in the previously announced deal in
Canada that Puration is working on with North American Cannabis
Holdings, Inc. (USOTC:
USMJ). Together, USMJ and PURA have been developing an
opportunity to acquire a grow operation in Canada in advance of the
pending nationwide legalization of recreational marijuana expected
this coming July. The comprehensive acquisition deal includes PURA
establishing and extraction facility and cannabis infused beverage
operation. PURA now expects to close the extraction and
beverage operation business in advance of the grow operation
acquisition. The extraction and beverage business deal is
anticipated to be finalized as early as by the end of this week.
The comprehensive acquisition deal remains on track and a letter of
intent on the USMJ acquisition of the grow operation remains
imminent.
For more information on Puration,
visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This news release contains
forward-looking statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and
uncertainties. Among others, these risks include the expectation
that any of the companies mentioned herein will achieve significant
sales, the failure to meet schedule or performance requirements of
the companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024